ClinTrial Research provides end‑to‑end clinical trial site management services, leveraging an AI‑driven platform and a network of specialized site partners to streamline study execution across therapeutic areas such as CNS, respiratory, and internal medicine. By integrating innovative technology with industry expertise, they aim to improve trial efficiency, ensure ethical conduct, and accelerate the delivery of new treatments to patients.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical trial sponsors often face delays and high costs due to fragmented site management, limited coordination among site partners, and inefficient data collection processes, which can impede timely study completion and patient access to new therapies.
Solution
ClinTrial Research offers end‑to‑end site management services that connect sponsors with an elite network of vetted clinical sites across multiple therapeutic areas, including behavioral health, CNS, respiratory, internal medicine, gastrointestinal, nephrology, and ophthalmology. The company leverages an AI‑driven technology platform to automate study start‑up, patient recruitment, EMR integration, and data capture, improving operational efficiency and reducing timelines. By maintaining rigorous quality and ethical standards, ClinTrial ensures consistent trial execution while fostering strong investigator and patient engagement. The integrated approach delivers coordinated site oversight, real‑time monitoring, and streamlined reporting, helping sponsors achieve on‑time, high‑quality trial outcomes.
Target Audience
Primary customers are pharmaceutical sponsors, contract research organizations (CROs), and biotech companies seeking comprehensive site management and accelerated trial delivery across the listed therapeutic areas.
Features
- AI‑powered platform that automates site selection, start‑up tasks, and patient enrollment workflows
- Centralized data collection hub with EMR integration for real‑time capture and monitoring of trial data
- Managed network of board‑certified principal investigators across seven therapeutic divisions
- Built‑in quality and compliance controls to ensure ethical conduct and regulatory adherence
- Continuous site coordination and communication tools that provide sponsors with transparent progress dashboards
- Diversity‑focused recruitment strategies to ensure representative patient populations